ACETAMINOPHEN AND CODEINE PHOSPHATE

Acetaminophen And Codeine Phosphate Adverse Events Reported to the FDA Over Time

How are Acetaminophen And Codeine Phosphate adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Acetaminophen And Codeine Phosphate, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Acetaminophen And Codeine Phosphate is flagged as the suspect drug causing the adverse event.

Most Common Acetaminophen And Codeine Phosphate Adverse Events Reported to the FDA

What are the most common Acetaminophen And Codeine Phosphate adverse events reported to the FDA?

Completed Suicide	144 (4.27%)
Vomiting	72 (2.13%)
Overdose	57 (1.69%)
Drug Exposure During Pregnancy	48 (1.42%)
Loss Of Consciousness	41 (1.21%)
Drug Interaction	40 (1.18%)
Multiple Drug Overdose Intentional	40 (1.18%)
Drug Toxicity	37 (1.1%)
Drug Abuse	33 (.98%)
Dyspnoea	33 (.98%)
Cardiac Arrest	32 (.95%)
	Show More
Hypotension	30 (.89%)
Medication Error	29 (.86%)
Malaise	28 (.83%)
Alanine Aminotransferase Increased	27 (.8%)
Cardio-respiratory Arrest	27 (.8%)
Intra-uterine Death	27 (.8%)
Intentional Drug Misuse	26 (.77%)
Multiple Drug Overdose	26 (.77%)
Poisoning	26 (.77%)
Pyrexia	26 (.77%)
Somnolence	26 (.77%)
Confusional State	25 (.74%)
Dizziness	24 (.71%)
Metabolic Acidosis	24 (.71%)
Respiratory Arrest	24 (.71%)
Nausea	23 (.68%)
Acidosis	22 (.65%)
Back Pain	21 (.62%)
Congenital Multiplex Arthrogryposis	21 (.62%)
Drug Ineffective	21 (.62%)
Constipation	20 (.59%)
Death	20 (.59%)
Atrial Fibrillation	19 (.56%)
Intentional Overdose	18 (.53%)
Macrocytosis	18 (.53%)
Tachycardia	18 (.53%)
Hepatic Necrosis	17 (.5%)
Rash	17 (.5%)
Renal Failure	17 (.5%)
Diarrhoea	16 (.47%)
Hyperhidrosis	16 (.47%)
Hypoxia	16 (.47%)
Suicide Attempt	16 (.47%)
Unresponsive To Stimuli	16 (.47%)
Abdominal Pain	15 (.44%)
Deafness Neurosensory	15 (.44%)
Headache	15 (.44%)
Respiratory Failure	15 (.44%)
Aspartate Aminotransferase Increase...	14 (.41%)
Depressed Level Of Consciousness	14 (.41%)
Dry Mouth	14 (.41%)
Fall	14 (.41%)
Inadequate Analgesia	14 (.41%)
International Normalised Ratio Incr...	14 (.41%)
Liver Function Test Abnormal	14 (.41%)
Blood Pressure Increased	13 (.39%)
Dehydration	13 (.39%)
Drug Dependence	13 (.39%)
Neutropenia	13 (.39%)
Pruritus	13 (.39%)
Tinnitus	13 (.39%)
Tremor	13 (.39%)
Urticaria	13 (.39%)
White Blood Cell Count Decreased	13 (.39%)
Agitation	12 (.36%)
Blood Alkaline Phosphatase Increase...	12 (.36%)
Coma	12 (.36%)
Hypersensitivity	12 (.36%)
Swelling Face	12 (.36%)
Accidental Overdose	11 (.33%)
Cytolytic Hepatitis	11 (.33%)
Hallucination	11 (.33%)
Heart Rate Increased	11 (.33%)
Insomnia	11 (.33%)
Pain In Extremity	11 (.33%)
Pancreatitis Acute	11 (.33%)
Thirst	11 (.33%)
Abortion Spontaneous	10 (.3%)
Acute Hepatic Failure	10 (.3%)
Apnoea	10 (.3%)
Blood Creatine Phosphokinase Increa...	10 (.3%)
Depression	10 (.3%)
Gamma-glutamyltransferase Increased	10 (.3%)
Lethargy	10 (.3%)
Liver Injury	10 (.3%)
Pain	10 (.3%)
White Blood Cell Count Increased	10 (.3%)
Angioedema	9 (.27%)
Blood Creatinine Increased	9 (.27%)
Convulsion	9 (.27%)
Drug Dispensing Error	9 (.27%)
Hepatic Encephalopathy	9 (.27%)
Miosis	9 (.27%)
Oedema	9 (.27%)
Pregnancy	9 (.27%)
Sopor	9 (.27%)
Stevens-johnson Syndrome	9 (.27%)
Decreased Appetite	8 (.24%)
Drug Withdrawal Syndrome Neonatal	8 (.24%)
Electrocardiogram Abnormal	8 (.24%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Acetaminophen And Codeine Phosphate, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Acetaminophen And Codeine Phosphate is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Acetaminophen And Codeine Phosphate

What are the most common Acetaminophen And Codeine Phosphate adverse events reported to the FDA?

Medication Errors	215 (6.37%)
Neurological	186 (5.51%)
Suicidal And Self-injurious Behavio...	177 (5.24%)
Respiratory	143 (4.24%)
Gastrointestinal Signs	140 (4.15%)
Chemical Injury And Poisoning	136 (4.03%)
Epidermal And Dermal Conditions	133 (3.94%)
Cardiac Arrhythmias	128 (3.79%)
Hepatic And Hepatobiliary	99 (2.93%)
Therapeutic And Nontherapeutic Effe...	82 (2.43%)
Hepatobiliary	80 (2.37%)
	Show More
Psychiatric	80 (2.37%)
Hematology Investigations	77 (2.28%)
Cardiac And Vascular Investigations	61 (1.81%)
Acid-base	48 (1.42%)
Abortions And Stillbirth	41 (1.21%)
Musculoskeletal And Connective Tiss...	41 (1.21%)
Gastrointestinal Motility And Defec...	39 (1.16%)
Renal Disorders	38 (1.13%)
Decreased And Nonspecific Blood Pre...	37 (1.1%)
Injuries	35 (1.04%)
Deliria	34 (1.01%)
Movement Disorders	33 (.98%)
Allergic Conditions	32 (.95%)
Infections - Pathogen Unspecified	32 (.95%)
Metabolic, Nutritional And Blood Ga...	29 (.86%)
Musculoskeletal And Connective Tiss...	29 (.86%)
Body Temperature Conditions	28 (.83%)
Fatal Outcomes	27 (.8%)
White Blood Cell	27 (.8%)
Electrolyte And Fluid Balance Condi...	25 (.74%)
Physical Examination Topics	25 (.74%)
Enzyme	23 (.68%)
Lower Respiratory Tract Disorders	23 (.68%)
Sleep Disorders	23 (.68%)
Angiedema And Urticaria	22 (.65%)
Central Nervous System Vascular	22 (.65%)
Red Blood Cell	22 (.65%)
Disturbances In Thinking	20 (.59%)
Gastrointestinal Hemorrhages	20 (.59%)
Headaches	20 (.59%)
Renal And Urinary Tract Investigati...	20 (.59%)
Procedural And Device Related Injur...	19 (.56%)
Seizures	19 (.56%)
Urinary Tract Signs	18 (.53%)
Appetite And General Nutritional	17 (.5%)
Encephalopathies	17 (.5%)
Ocular Neuromuscular	17 (.5%)
Pregnancy, Labour, Delivery And Pos...	17 (.5%)
Salivary Gland Conditions	17 (.5%)
Exocrine Pancreas Conditions	16 (.47%)
Lifestyle Issues	16 (.47%)
Skin Appendage Conditions	16 (.47%)
Hearing	15 (.44%)
Muscle	15 (.44%)
Toxicology And Therapeutic Drug Mon...	15 (.44%)
Anxiety Disorders	13 (.39%)
Inner Ear And Viiith Cranial Nerve	13 (.39%)
Water, Electrolyte And Mineral	13 (.39%)
Cardiac Disorder Signs	12 (.36%)
Depressed Mood Disorders	11 (.33%)
Tongue Conditions	11 (.33%)
Coagulopathies And Bleeding Diathes...	10 (.3%)
Skin Vascular Abnormalities	10 (.3%)
Vascular	10 (.3%)
Joint	9 (.27%)
Mental Impairment	9 (.27%)
Microbiology And Serology	9 (.27%)
Obstetric And Gynecological Therape...	9 (.27%)
Peritoneal And Retroperitoneal Cond...	9 (.27%)
Bronchial Disorders	8 (.24%)
Gastrointestinal	8 (.24%)
Gastrointestinal Inflammatory Condi...	8 (.24%)
Glucose Metabolism Disorders	8 (.24%)
Personality Disorders	8 (.24%)
Upper Respiratory Tract Disorders	8 (.24%)
Bacterial Infectious	7 (.21%)
Changes In Physical Activity	7 (.21%)
Fetal Complications	7 (.21%)
Heart Failures	7 (.21%)
Neuromuscular	7 (.21%)
Pleural	7 (.21%)
Product Quality Issues	7 (.21%)
Protein And Chemistry Analyses	7 (.21%)
Therapeutic Procedures And Supporti...	7 (.21%)
Bone And Joint Injuries	6 (.18%)
Gastrointestinal Stenosis And Obstr...	6 (.18%)
Gastrointestinal Ulceration And Per...	6 (.18%)
Hematological And Lymphoid Tissue T...	6 (.18%)
Oral Soft Tissue Conditions	6 (.18%)
Platelet	6 (.18%)
Vascular Hypertensive	6 (.18%)
Coronary Artery	5 (.15%)
Fungal Infectious	5 (.15%)
Musculoskeletal And Connective Tiss...	5 (.15%)
Bile Duct	4 (.12%)
Bone Disorders	4 (.12%)
Cardiac And Vascular Disorders Cong...	4 (.12%)
Cardiac Valve	4 (.12%)
Embolism And Thrombosis	4 (.12%)
Lymphatic Vessel	4 (.12%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Acetaminophen And Codeine Phosphate, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Acetaminophen And Codeine Phosphate is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.